Published in J Biol Chem on January 21, 2010
Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab (2012) 3.26
Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med (2011) 3.20
Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr (2011) 2.01
Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia (2011) 1.93
Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol (2014) 1.71
Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab (2013) 1.58
Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats. Am J Physiol Endocrinol Metab (2010) 1.38
Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism. Mol Metab (2016) 1.38
Toward a unifying hypothesis of metabolic syndrome. Pediatrics (2012) 1.36
Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab (2012) 1.35
Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care (2012) 1.27
Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism (2013) 1.20
Branched-chain amino acids, mitochondrial biogenesis, and healthspan: an evolutionary perspective. Aging (Albany NY) (2011) 1.09
Leucine and protein metabolism in obese Zucker rats. PLoS One (2013) 1.07
Metabolic remodeling of white adipose tissue in obesity. Am J Physiol Endocrinol Metab (2014) 1.06
Metabolically healthy and unhealthy obese--the 2013 Stock Conference report. Obes Rev (2014) 1.04
Integrated analysis of transcript-level regulation of metabolism reveals disease-relevant nodes of the human metabolic network. Nucleic Acids Res (2013) 1.03
Plasma amino acid profiles are associated with insulin, C-peptide and adiponectin levels in type 2 diabetic patients. Nutr Diabetes (2014) 0.99
Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis. Nat Chem Biol (2015) 0.99
Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J Diabetes (2012) 0.98
Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease. PLoS One (2015) 0.95
Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. Am J Physiol Endocrinol Metab (2015) 0.93
Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders. Hum Mol Genet (2014) 0.91
A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids. Metabolomics (2013) 0.88
Effect of insulin sensitizer therapy on amino acids and their metabolites. Metabolism (2015) 0.87
Impact of combined resistance and aerobic exercise training on branched-chain amino acid turnover, glycine metabolism and insulin sensitivity in overweight humans. Diabetologia (2015) 0.86
An amino acid profile to predict diabetes? Nat Med (2011) 0.86
Tissue-specific and nutrient regulation of the branched-chain α-keto acid dehydrogenase phosphatase, protein phosphatase 2Cm (PP2Cm). J Biol Chem (2012) 0.84
Application of combined omics platforms to accelerate biomedical discovery in diabesity. Ann N Y Acad Sci (2013) 0.83
Adipose transplant for inborn errors of branched chain amino acid metabolism in mice. Mol Genet Metab (2013) 0.82
The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism. Nutrients (2016) 0.81
Metabolomics and Metabolic Diseases: Where Do We Stand? Cell Metab (2016) 0.81
The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer. Nutr Metab (Lond) (2012) 0.81
Association between arterial stiffness and serum L-octanoylcarnitine and lactosylceramide in overweight middle-aged subjects: 3-year follow-up study. PLoS One (2015) 0.80
Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes. Mol Endocrinol (2015) 0.80
Disruption of Adipose Rab10-Dependent Insulin Signaling Causes Hepatic Insulin Resistance. Diabetes (2016) 0.80
Adipose tissue monomethyl branched-chain fatty acids and insulin sensitivity: Effects of obesity and weight loss. Obesity (Silver Spring) (2014) 0.80
Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export. Mol Metab (2016) 0.79
Metabolic modeling of muscle metabolism identifies key reactions linked to insulin resistance phenotypes. Mol Metab (2015) 0.79
Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals. Nutr Metab (Lond) (2016) 0.78
The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review. J Diabetes Res (2016) 0.78
Muscle-specific deletion of BDK amplifies loss of myofibrillar protein during protein undernutrition. Sci Rep (2017) 0.77
Catabolism of Branched Chain Amino Acids Contributes Significantly to Synthesis of Odd-Chain and Even-Chain Fatty Acids in 3T3-L1 Adipocytes. PLoS One (2015) 0.77
Systems view of adipogenesis via novel omics-driven and tissue-specific activity scoring of network functional modules. Sci Rep (2016) 0.77
Effects of sex and site on amino acid metabolism enzyme gene expression and activity in rat white adipose tissue. PeerJ (2015) 0.76
Effects of leucine supplementation and serum withdrawal on branched-chain amino acid pathway gene and protein expression in mouse adipocytes. PLoS One (2014) 0.76
Associations between plasma branched-chain amino acids, β-aminoisobutyric acid and body composition. J Nutr Sci (2016) 0.76
Fat-specific Dicer deficiency accelerates aging and mitigates several effects of dietary restriction in mice. Aging (Albany NY) (2016) 0.76
Metabolomics in the developmental origins of obesity and its cardiometabolic consequences. J Dev Orig Health Dis (2015) 0.76
Gender-specific effects of intrauterine growth restriction on the adipose tissue of adult rats: a proteomic approach. Proteome Sci (2015) 0.76
Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury. Cell Metab (2017) 0.75
Maternal Diabetes Leads to Adaptation in Embryonic Amino Acid Metabolism during Early Pregnancy. PLoS One (2015) 0.75
Weight loss is associated with plasma free amino acid alterations in subjects with metabolic syndrome. Nutr Diabetes (2016) 0.75
Branched-chain amino acids differently modulate catabolic and anabolic states in mammals: a pharmacological point of view. Br J Pharmacol (2016) 0.75
Enhanced GLUT4-Dependent Glucose Transport Relieves Nutrient Stress in Obese Mice Through Changes in Lipid and Amino Acid Metabolism. Diabetes (2016) 0.75
Unaffected arm muscle hypercatabolism in dysphagic subacute stroke patients: the effects of essential amino acid supplementation. Biomed Res Int (2014) 0.75
Effect of Green Tea Extract on Systemic Metabolic Homeostasis in Diet-Induced Obese Mice Determined via RNA-Seq Transcriptome Profiles. Nutrients (2016) 0.75
The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population. Lipids Health Dis (2016) 0.75
Visceral adipose tissue but not subcutaneous adipose tissue is associated with urine and serum metabolites. PLoS One (2017) 0.75
Gene expression profile of subcutaneous adipose tissue in BMI-discordant monozygotic twin pairs unravels molecular and clinical changes associated with sub-types of obesity. Int J Obes (Lond) (2017) 0.75
Amino Acid Signatures to Evaluate the Beneficial Effects of Weight Loss. Int J Endocrinol (2017) 0.75
Genetic regulation of adipose tissue transcript expression is involved in modulating serum triglyceride and HDL-cholesterol. Gene (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A (2001) 68.44
Upstream and downstream of mTOR. Genes Dev (2004) 21.61
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest (2002) 21.08
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature (2004) 12.36
A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab (2009) 11.46
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature (2005) 10.10
Hypothalamic mTOR signaling regulates food intake. Science (2006) 8.62
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature (2001) 6.70
Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N Engl J Med (1999) 5.05
Plasma amino acid levels and insulin secretion in obesity. N Engl J Med (1969) 4.18
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest (2000) 3.41
Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab (2007) 3.30
Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem (2001) 3.19
Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem (1993) 3.02
Branched-chain amino acid metabolism. Annu Rev Nutr (1984) 2.58
Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab (2007) 2.46
Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest (1976) 2.27
A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr (1998) 2.09
Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med (2008) 1.94
The role of leucine in weight loss diets and glucose homeostasis. J Nutr (2003) 1.86
Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci U S A (2009) 1.75
Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. J Nutr (2006) 1.63
Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR. Am J Physiol Endocrinol Metab (2003) 1.47
Mechanisms responsible for regulation of branched-chain amino acid catabolism. Biochem Biophys Res Commun (2004) 1.40
Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am J Physiol Endocrinol Metab (2001) 1.40
Transaminase of branched chain amino acids. I. Branched chain amino acids-alpha-ketoglutarate transaminase. J Biochem (1966) 1.35
Tissue-specific effects of chronic dietary leucine and norleucine supplementation on protein synthesis in rats. Am J Physiol Endocrinol Metab (2002) 1.29
Impaired growth and neurological abnormalities in branched-chain alpha-keto acid dehydrogenase kinase-deficient mice. Biochem J (2006) 1.27
Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves. Am J Physiol Endocrinol Metab (2003) 1.21
Metabolic fate of leucine: a significant sterol precursor in adipose tissue and muscle. Am J Physiol (1974) 1.14
Enzymes, metabolites and fluxes. J Exp Bot (2004) 1.08
EFFECT OF GLUCOSE INFUSION ON THE INDIVIDUAL PLASMA FREE AMINO ACIDS IN MAN. Proc Soc Exp Biol Med (1964) 1.06
Effect of fasting and fasting-refeeding on conversion of leucine into CO 2 and lipids in rats. Am J Physiol (1972) 1.02
Site of action of insulin in promoting leucine utilization in adipose tissue. Am J Physiol (1977) 1.01
LEUCINE-INDUCED HYPOGLYCEMIA. N Engl J Med (1965) 0.98
Leucine degradation and release of glutamine and alanine by adipose tissue. J Biol Chem (1980) 0.94
Dietary control and tissue specific expression of branched-chain alpha-ketoacid dehydrogenase kinase. Arch Biochem Biophys (1995) 0.92
Effect of endogenous insulin on human amino acid metabolism. Diabetes (1966) 0.90
Rat adipose tissue amino acid metabolism in vivo as assessed by microdialysis and arteriovenous techniques. Am J Physiol (1997) 0.89
Regulation of branched-chain alpha-keto acid dehydrogenase kinase expression in rat liver. J Nutr (2001) 0.88
Alanine release by rat adipose tissue in vitro. Biochem Biophys Res Commun (1977) 0.87
Inhibition of branched-chain alpha-keto acid dehydrogenase kinase by alpha-chloroisocaproate. Methods Enzymol (1988) 0.86
Glucocorticoid-mediated activation of muscle branched-chain alpha-keto acid dehydrogenase in vivo. Am J Physiol (1987) 0.86
Amino acid metabolism in human subcutaneous adipose tissue in vivo. Clin Sci (Lond) (1991) 0.85
pH regulation of mitochondrial branch chain alpha-keto acid transport and oxidation in rat heart mitochondria. J Biol Chem (1987) 0.84
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature (2005) 10.10
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med (2006) 9.53
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature (2002) 8.77
Extended longevity in mice lacking the insulin receptor in adipose tissue. Science (2003) 8.53
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature (2004) 7.64
Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell (2002) 5.01
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med (2009) 3.97
A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A (2007) 3.76
Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med (2006) 3.66
PTP1B regulates leptin signal transduction in vivo. Dev Cell (2002) 3.61
Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab (2005) 3.51
The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes (2007) 3.42
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature (2012) 3.35
Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab (2007) 3.30
Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes (2005) 3.04
Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab (2007) 2.69
A high-fat, ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab (2007) 2.64
Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res (2004) 2.62
Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A (2005) 2.60
Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab (2007) 2.46
Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem (2010) 2.19
Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem (2006) 2.13
Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest (2006) 2.09
Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem (2008) 2.08
AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol (2006) 2.06
Lessons on conditional gene targeting in mouse adipose tissue. Diabetes (2013) 2.04
Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes (2008) 1.88
Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab (2007) 1.85
Role of Rho-kinase in regulation of insulin action and glucose homeostasis. Cell Metab (2005) 1.73
Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Biol Chem (2003) 1.72
Regulation of gluconeogenesis by Krüppel-like factor 15. Cell Metab (2007) 1.71
Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab (2005) 1.67
Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol Cell Biol (2007) 1.66
Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. Diabetes (2004) 1.65
Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction. Diabetes (2003) 1.62
Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol (2005) 1.61
Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol (2012) 1.59
Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab (2013) 1.58
The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents. J Pediatr (2008) 1.54
GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J Clin Invest (2004) 1.47
Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol (2007) 1.46
Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol (2005) 1.41
AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell (2013) 1.41
Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest (2009) 1.36
Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab (2010) 1.36
Gastric bypass surgery alters behavioral and neural taste functions for sweet taste in obese rats. Am J Physiol Gastrointest Liver Physiol (2010) 1.36
p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake. Cell Metab (2012) 1.35
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab (2004) 1.33
Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta-/- mice. Mol Cell Biol (2004) 1.32
Leucine supplementation of drinking water does not alter susceptibility to diet-induced obesity in mice. J Nutr (2009) 1.28
Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem (2004) 1.25
Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/-mice. J Biol Chem (2005) 1.23
CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep (2011) 1.23
Phosphatidyl inositol 3-kinase signaling in hypothalamic proopiomelanocortin neurons contributes to the regulation of glucose homeostasis. Endocrinology (2009) 1.23
Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am J Physiol Endocrinol Metab (2008) 1.23
Nutrient signaling components controlling protein synthesis in striated muscle. J Nutr (2007) 1.22
Challenges and opportunities of defining clinical leptin resistance. Cell Metab (2012) 1.21
Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab (2011) 1.21
Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda /zeta but not on glycogen synthase kinase-3. J Biol Chem (2002) 1.20
Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg (2009) 1.20
Nutrient sensor links obesity with diabetes risk. Nat Med (2004) 1.19
Deletion of cd39/entpd1 results in hepatic insulin resistance. Diabetes (2008) 1.18
Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes (2004) 1.18
Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis. Am J Physiol Endocrinol Metab (2009) 1.18
GLUT4 overexpression or deficiency in adipocytes of transgenic mice alters the composition of GLUT4 vesicles and the subcellular localization of GLUT4 and insulin-responsive aminopeptidase. J Biol Chem (2004) 1.16
Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects. Diabetes (2002) 1.15
Role of hypothalamic adenosine 5'-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology (2006) 1.14
Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. J Biol Chem (2011) 1.13
Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes (2007) 1.12
Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis. PLoS One (2012) 1.12
Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. J Biol Chem (2007) 1.12
Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues. Mol Cell Biol (2009) 1.12
Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study. Circulation (2013) 1.11
Disruption of BCAA metabolism in mice impairs exercise metabolism and endurance. J Appl Physiol (1985) (2010) 1.09
Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity (Silver Spring) (2006) 1.09
Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expression. J Biol Chem (2004) 1.07
Leucine and protein metabolism in obese Zucker rats. PLoS One (2013) 1.07
Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. Am J Physiol Gastrointest Liver Physiol (2010) 1.07
Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophr Bull (2010) 1.06
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. J Oncol Pharm Pract (2010) 1.06
Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine. Am J Physiol Endocrinol Metab (2010) 1.05
Adipose tissue dysregulation and reduced insulin sensitivity in non-obese individuals with enlarged abdominal adipose cells. Diabetol Metab Syndr (2012) 1.03
Rapamycin blunts nutrient stimulation of eIF4G, but not PKCepsilon phosphorylation, in skeletal muscle. Am J Physiol Endocrinol Metab (2007) 1.02
Downregulation of STRA6 in adipocytes and adipose stromovascular fraction in obesity and effects of adipocyte-specific STRA6 knockdown in vivo. Mol Cell Biol (2014) 1.02